Cardiovascular risk factors and cognitive decline in adults aged 50 and over: A population-based cohort study

Age and Ageing

Volumn 42, Issue 3, 2013, Pages 338-345

  Dregan, Alex ^a   Stewart, Robert ^b   Gulliford, Martin C ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cognition; Older people; Prospective study; Risk score; Vascular factors

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL DETERIORATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMOKING; SYSTOLIC BLOOD PRESSURE; Z SCORE;

AGE FACTORS; AGING; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; COGNITION; COGNITION DISORDERS; ENGLAND; EXECUTIVE FUNCTION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LINEAR MODELS; LONGITUDINAL STUDIES; MEMORY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SYSTOLE; TIME FACTORS;

EID: 84877024880     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afs166     Document Type: Article

References (27)

1. Arntzen KA, Schirmer H, Wilsgaard T et al.. Impact of cardiovascular risk factors on cognitive function: the Tromso study. Eur J Neurol 2011; 18: 737-43.
2. Stephan MC, Brayne C. Vascular factors and prevention of dementia. Int R Psychiat 2008; 20: 344-56.
3. Glynn RJ, Beckett LA, Herbet LE et al.. Current and remote blood pressure and cognitive decline. JAMA 1999; 281: 438-45.
4. Kilander L, Nyman H, Boberg M et al.. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998; 31: 780-6.
5. Kivipelto M, Helkala EL, Hanninen T et al.. Midlife vascular risk factors and late-life mild cognitive impairment: a population study. Neurology 2001; 56: 1683-9.
6. Solomon A, Kåreholt I, Ngandu T et al.. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology 2007; 68: 751-6.
7. van den Kommer TN, Dik MG, Comijs HC et al.. Total cholesterol and oxysterols: early markers for cognitive decline in elderly? Neurobiol Aging 2009; 30: 534-45.
8. Yaffe K, Barrett-Connor E, Lin F et al.. Serum lipoprotein levels, statin use, and cognitive functioning in older women. Arch Neurol 2002; 59: 378-84.
9. Debette S, Seshadri S, Beiser A et al.. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011; 77: 461-8.
10. Fitzpatrick AL, Kuller LH, Lopez OL et al.. Midlife and latelife obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009; 66: 336-42.
11. Anstey KJ, von Sanden C, Salim A et al.. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007; 166: 367-78.
12. Sabia S, Marmot M, Dufouil C et al.. Smoking history and cognitive function in middle age from the Whitehall II study. Arch Intern Med 2008; 168: 1165-73.
13. Llewellyn D, Lang IA, Xie J et al.. Framingham stroke risk profile and poor cognitive functioning: a population-based study. BMC Neourol 2008; 8-12.
14. Seshadri S, Wolf PA, Beiser A et al.. Stroke risk profile, brain volume, and cognitive function. The Framingham Offspring Study. Neurology 2004; 63: 1591-9.
15. Kaffashian S, Dugravot A, Nabi H et al.. Predictive utility of the Framingham general cardiovascular risk profile for cognitive function: evidence from the Whitehall II study. Eur Heart J 2011; 32: 2326-32.
16. Scholes S, Taylor R, Cheshire H et al.. Technical Report (wave 2): Retirement, Health and Relationships of the Older Population in England: the 2004 English Longitudinal Study of Ageing. London: National Centre for Social Research, 2008.
17. Baars MA, van Boxtel MP, Dijkstra JB et al.. Predictive value of mild cognitive impairment for dementia: the influence of case definition and age. Dement Geriatr Cogn Disord 2009; 27: 173-81.
18. Herzog AR, Wallace RB. Measures of cognitive functioning in the AHEAD Study. J Gerontol B Psychol Sci Soc Sci 1997; 52 (special issue): 37-48.
19. Anderson KM, Odell PM, Wilson PWF et al.. Cardiovascular disease risk profiles. Am Heart J 1991; 293-8.
20. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. App Psychol Meas 1977; 1: 385-401.
21. Goldberg DP. Manual of the General Health Questionnaire. Slough, England: National Foundation for Education Research, 1978.
22. Elias PK, Elias MF, Robbins MA et al.. Blood pressure-related cognitive decline: does age make a difference? Hypertension 2004; 44: 631-6.
23. Haan M, Shemanski L, Jagust WJ et al.. The role of APOE 4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999; 282: 40-6.
24. Applegate WB, Pressel S, Wittes J et al.. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 1994; 154: 2154-60.
25. Lithell H, Hansson L, Skoog I et al.. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875-86.
26. Prince MJ, Bird AS, Blizard RA et al.. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. BMJ 1996; 312: 801-5.
27. Richards M, Jarvis MJ, Thompson N, Wadsworth MJE. Cigarette smoking and cognitive decline in midlife: evidence from a perspective birth cohort study. Am J Pub Health 2003; 9: 994-8.